Suraksha Diagnostic Limited is coming up with an IPO with an offer to sell 1.92 crore shares worth INR 846.25 crores. The company aims to enhance visibility and brand image and create a public market through equity listing.
Suraksha Diagnostic IPO – Important Dates
| Suraksha Diagnostic Limited IPO Date | November 29, 2024 to December 3, 2024 |
| Suraksha Diagnostic Limited IPO Listing Date | December 6, 2024 |
| Suraksha Diagnostic Limited IPO Price | INR 420-441 per share |
| Suraksha Diagnostic Limited IPO Lot Size | 34 Shares |
| Suraksha Diagnostic Limited IPO Total Issue Size | INR 846.25 crores |
| Suraksha Diagnostic Limited IPO Basis of Allotment | December 4, 2024 |
| Suraksha Diagnostic Limited IPO Initiation of Refunds | December 5, 2024 |
| Suraksha Diagnostic Limited IPO Credit of Shares to Demat | December 5, 2024 |
| Suraksha Diagnostic Limited IPO Issue Type | Book Built Issue IPO |
| Suraksha Diagnostic Limited IPO Listing At | BSE NSE |
Suraksha Diagnostic Limited IPO – Company Profile
Suraksha Diagnostic Limited provides comprehensive pathology, radiology, and medical consultation services through a network of a central reference lab, eight satellite labs, 49 diagnostic centers, and 166 sample collection centers across West Bengal, Bihar, Assam, and Meghalaya.
With a strong brand and extensive network, Suraksha Diagnostic Limited offers 2,300+ diagnostic tests, including specialized pathology and radiology services. The company also provides vaccinations and customized test packages for early disease detection.
Suraksha Diagnostic Limited uses a cluster-based hub-and-spoke model to offer comprehensive diagnostics through 13 hub centers, 36 spoke centers, and 166 sample collection centers, enhancing testing efficiency and expanding access to remote regions.
Suraksha Diagnostic Ltd IPO Fundamental Analysis
Suraksha Diagnostic Limited’s financial analysis reveals a mixed performance. Revenue declined while equity and total assets grew, indicating potential expansion. However, reduced profitability, lower EPS, and decreased RoNW may concern investors.
- Revenue Trend: The revenue decreased from ₹2,231.93 millions in March 2022 to ₹1,901.34 millions in March 2023. The revenue for the current year’s 3-month period ending June 2024 is INR 607.32 millions.
- Equity and Liabilities: Equity has shown a consistent increase over the periods, reflecting potential growth and expansion.
- Profitability: The profit after tax (PAT) has significantly decreased from ₹208.24 million in March 2022 to ₹76.67 million by June 2024. This decline in profitability could be a source of concern among investors.
- Earnings per Share (EPS): The diluted EPS has reduced from ₹3.91 in March 2022 to ₹1.49 by June 2024, reflecting lower earnings per share for investors.
- Return on Net Worth (RoNW): The RoNW has reduced from 15.38% to 4.33%, indicating a decrease in the company’s ability to generate returns on shareholder equity.
- Financial Position: Total assets have increased, suggesting potential business growth.
Check out the other upcoming IPOs this month:
| Upcoming IPO | IPO Going Live |
| Rosmerta Digital Services Limited IPO | N/A |
| Avanse Financial Services Limited IPO | N/A |
| Nisus Finance Services Co Limited IPO | Dec 4, 2024 |
| Ganesh Infraworld Limited IPO | Nov 29, 2024 |
| Property Share Investment Trust SM REIT | Dec 02, 2024 |
Suraksha Diagnostic IPO Financial Analysis
| Particular | As of 31 March 2022 | As of 31 March 2023 | As of 30 June 2024 |
| Revenue (₹ in millions) | 2,231.93 | 1,901.34 | 607.32 |
| Equity (₹ in millions) | 1,458.28 | 1,554.61 | 1,866.17 |
| Expenses (₹ in millions) | 1,977.56 | 1,869.39 | 513.35 |
| Profit and Loss After Tax (₹ in millions) | 208.24 | 60.65 | 76.67 |
| Diluted EPS only (₹) | 3.91 | 1.22 | 1.49 |
| Return on Net Worth (%) | 15.38 | 4.32 | 4.33 |
| NAV per Equity Share (₹) | 27.36 | 29.25 | 35.09 |
| Total Assets (in millions) | 2,759.59 | 2,811.95 | 3,141.99 |
| Total Liabilities (in millions) | 1,301.31 | 1,257.34 | 1,275.82 |
Suraksha Diagnostic Limited IPO Peer Comparison
Suraksha Diagnostic Limited and its competitors, Dr. Lal PathLabs, Metropolis Healthcare, Thyrocare, and Vijaya Diagnostic, vary in market positions. Differences are evident in share prices, return ratios, and valuations, reflecting distinct financial health and growth prospects.
| Company | Total Income (₹ in millions) | Face Value per Equity Share (₹) | P/E Ratio | EPS (Basic) (₹) | EPS (Diluted) (₹) | RoNW (%) | NAV (₹ per share) |
| Suraksha Diagnostic Limited | 2,222.60 | 2 | NA | 4.43 | 4.43 | 14.09 | 33.66 |
| Dr Lal PathLabs | 22,266.00 | 10 | 77.08 | 43.05 | 42.98 | 20.35 | 221.53 |
| Metropolis Healthcare | 12,077.09 | 2 | 89.61 | 24.95 | 24.87 | 12.26 | 213.98 |
| Thyrocare | 5,723.90 | 10 | 65.52 | 13.42 | 13.40 | 13.34 | 99.48 |
| Vijaya Diagnostic | 5,478.05 | 1 | 86.40 | 11.62 | 11.59 | 19.77 | 64.21 |
Suraksha Diagnostic Ltd IPO Objective
The main objective of Suraksha Diagnostic Limited is to enhance visibility and brand image and create a public market through equity listing.
Suraksha Diagnostic IPO Risks And Challenges
Suraksha Diagnostic Limited’s risk includes the potential impact of non-compliance issues related to promoter group companies, competitive market share in East India, and dependence on the B2B segment, which contributes 6.52% of total revenue.
- Securities of Promoter Group companies, Akanksha Viniyog Limited and Senao International Limited, were previously frozen due to non-compliance. Revoked in 2022, they seek voluntary delisting from the Calcutta Stock Exchange, pending approval.
- The Indian diagnostics industry is highly competitive, with the market share in East India at 1.15-1.30%, compared to Dr Lal Pathlabs’ 5.30-5.70% in North India and Vijaya Diagnostics’ 2.20-2.50% in South India.
- The company’s B2B segment contributed 6.52% of total revenue. They are subject to contract cancellations, non-compliance with data protection laws, and potential penalties in government tenders, which may impact their operations.
Suraksha Diagnostic Ltd IPO – Industry & Market Potential
India’s healthcare industry, driven by an ageing population, lifestyle diseases, and technology adoption, grew at a 10-11% CAGR from FY17-FY24. It’s expected to reach ₹14.5-15.5 trillion by FY28, continuing the same growth rate.
The Indian diagnostics industry, growing at a 9-10% CAGR from FY17-FY24, is expected to expand at 10-12% CAGR between FY24-FY28, driven by urbanization, lifestyle diseases, increased healthcare awareness, and technological advancements in diagnostics.
By 2030, India’s doctor stock is projected to reach 1.51 million, up from 1.25 million in 2025, with the active healthcare workforce growing to 1.1 million, driven by new medical colleges and increased training.
Suraksha Diagnostic Limited IPO – Type of Offer
Suraksha Diagnostic Limited is offering to sell 1.92 crore existing shares worth INR 846.25 crores. The following are the details of the existing shareholders who are also the promoters selling the shares:
| Name of the promoter selling shareholder | No. of shares offered (in ₹ million) |
| Dr. Somnath Chatterjee | 2,132,148 |
| Ritu Mittal | 2,132,148 |
| Satish Kumar Verma | 2,132,148 |
Suraksha Diagnostic IPO Offer Size
The offer size of Suraksha Diagnostic Limited is INR 846.25 crores, consisting of an offer to sell 1.92 crore shares worth INR 846.25 crores. The company aims to enhance visibility and brand image and create a public market through equity listing.
Suraksha Diagnostic Limited IPO Allotment Structure
Suraksha Diagnostic Limited’s allocation will be as follows: 50% for Qualified Institutional Buyers (QIB), 15% for Non-Institutional Investors (NII), and 35% for Retail Individual Investors (RII) according to SEBI regulations.
● Qualified Institutional Buyers (QIB): As per SEBI regulations, 50% of the shares offered through the IPO will be reserved for Qualified Institutional Buyers. These include entities such as banks, mutual funds, and insurance companies.
● Non-Institutional Investors (NII): 15% of the shares will be reserved for Non-Institutional Investors. These typically include corporate bodies or individuals investing more than Rs.2 lakhs.
● Retail Individual Investors (RII): The remaining 35% of the shares will be allotted to Retail Individual Investors. These individual investors apply for shares with a total value of less than Rs.2 lakhs.
How to apply for Suraksha Diagnostic IPO?
To apply for the Suraksha Diagnostic Limited IPO through Alice Blue, follow these steps:
Open a Demat and Trading Account: If you don’t have one already, you must open a Demat and trading account with Alice Blue.
- Check for IPO Details: Once your account is active, you can check for the Suraksha Diagnostic Limited IPO details in the IPO section of the Alice Blue platform.
- Place the Bid: Enter the number of shares you wish to buy and place your bid within the IPO’s price band.
- Submit the Application: Confirm all your details and submit your application.
You can apply for the Suraksha Diagnostic Limited IPO at Alice Blue in just a few clicks!
Check Allotment Status: After the allotment process, you can check the allotment status to see if you have received any shares.
Please note that the allotment of shares is not guaranteed and will depend on the demand for the IPO.
How do you check Suraksha Diagnostic IPO Allotment Status?
Checking the allotment status of an IPO in Alice Blue is usually straightforward. Please follow these general steps:
- Log in to your Alice Blue Account: You can do this through the Alice Blue website or the trading app.
- Navigate to the Portfolio or IPO Section: This might differ based on the layout of Alice Blue’s platform, but generally, you can find the status of your IPO application under the ‘Portfolio’ or ‘IPO’ section.
- Find the IPO Allotment Status: Look for a sub-section called ‘IPO Allotment Status’ or something similar. This is where you can see the status of the IPOs you have applied for.
- Select the Suraksha Diagnostic Limited IPO: If you have applied for multiple IPOs, there might be a dropdown menu or a list where you can select the IPO you are interested in. Select the Suraksha Diagnostic Limited IPO.
- Check the Status: The status of your application should be displayed here. If the shares have been allocated to you, it would be mentioned here.
If you face any issues, we request you reach out to our customer support team at Alice Blue for detailed assistance.
Apart from Alice Blue, there are other ways to check the allotment status of the Suraksha Diagnostic Limited IPO:
● Registrar’s Website: Visit the website of Kfin Technologies Limited, the registrar of the Suraksha Diagnostic Limited IPO. On the homepage, look for the ‘IPO Allotment Status’ option. You must enter your PAN, application, or Demat account number to check your allotment status. Click on the ‘Submit’ button to view your IPO allotment status.
● BSE NSE: You can also check the allotment status on the official websites of the Bombay Stock Exchange (BSE) National Stock Exchange (NSE). You would need your application number and PAN to check the status.
Please note that the allotment status will only be available after completing the allotment process, a few days after the IPO window closes.
Suraksha Diagnostic Ltd IPO Offer Registrar
The registrar for the Suraksha Diagnostic Limited IPO is Kfin Technologies Limited. They are responsible for ensuring the IPO allotment and refund processes are carried out smoothly.
Contact information for the registrar:
KFin Technologies Limited
Selenium Tower B, Plot No. 31 and 32,
Financial District, Nanakramguda, Serilingampally
Hyderabad -500 032, Telangana, India
Telephone Number: +91 40 6716 2222
Email : [email protected]
Website: www.kfintech.com
Suraksha Clinic and Diagnostic IPO – FAQs
1. What is the allotment date of the Suraksha Diagnostic IPO?
The allotment date of the Suraksha Diagnostic is December 4, 2024.
2. What is the price band of the Suraksha Diagnostic IPO?
The price band of the issue is INR 420-441 per share.
3. What is the size of the Suraksha Diagnostic IPO?
The offer size of Suraksha Diagnostic Limited is INR 846.25 crores, consisting of an offer to sell 1.92 crore shares worth INR 846.25 crores. The company aims to enhance visibility and brand image and create a public market through equity listing.
4. What is the listing date of the Suraksha Diagnostic IPO?
The listing date of the Suraksha Diagnostic is December 6, 2024.
5. Where is the Suraksha Diagnostic IPO Getting Listed?
Suraksha Diagnostic is getting listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
6. What are the open and close dates of the Suraksha Diagnostic Limited IPO?
The open and close dates of Suraksha Diagnostic Limited are November 29, 2024, and December 3, 2024, respectively.
7. How to apply for Suraksha Diagnostic Ltd IPO in Alice Blue?
To apply for the Suraksha Diagnostic Limited IPO through Alice Blue, open a Demat and trading account, check IPO details, place your bid within the price band, and submit your application. After allotment, check the status to see if shares are allocated.
8. Who are the Book Runners for the Suraksha Diagnostic IPO?
The Book Runners for the Suraksha Diagnostic are ICICI Securities Limited, Nuvama Wealth Management Limited, and SBI Capital Markets Limited.
